Letters to the Editor
Efficacy of Janus kinase inhibitor baricitinib in the treatment of refractory juvenile dermatomyositis complicated by calcinosis
M.V. Mastrolia1, S.I. Orsini2, E. Marrani3, I. Maccora4, I. Pagnini5, G. Simonini6
- Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy. maria.mastrolia@unifi.it
- Department of Woman, Child and of General and Specialised Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
- Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
- Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
- Rheumatology Unit, Meyer Children’s University Hospital, Florence, Italy.
- Neurofarba Department, University of Florence, Italy.
CER16468
2023 Vol.41, N°2
PI 0402, PF 0403
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 36861743 [PubMed]
Received: 19/12/2022
Accepted : 24/01/2023
In Press: 01/03/2023
Published: 01/03/2023
